Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol sedation during LISA surfactant administration in preterm infants
2018-002876-41Phase 3Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS) comparing Propofol sedation during LISA with Placebo during LISA (2 arms). Primary endpoint: Rate of mechanical ventilation within 72 hours of life (overall). Started Aug 2018; status: active.
02
Drugs
propofol
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2018-002876-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002876-41.